UnitedHealth Group Incorporated (NYSE:UNH) Stake Decreased by Weaver Capital Management LLC

Weaver Capital Management LLC cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 4,201 shares of the healthcare conglomerate’s stock after selling 242 shares during the quarter. Weaver Capital Management LLC’s holdings in UnitedHealth Group were worth $2,456,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. Delta Financial Group Inc. grew its position in UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after purchasing an additional 17 shares in the last quarter. Signature Resources Capital Management LLC raised its stake in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares in the last quarter. Saxony Capital Management LLC lifted its holdings in UnitedHealth Group by 3.5% during the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after purchasing an additional 18 shares during the last quarter. GoalVest Advisory LLC increased its holdings in UnitedHealth Group by 0.6% during the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after purchasing an additional 18 shares in the last quarter. Finally, Fiduciary Group LLC raised its stake in shares of UnitedHealth Group by 0.5% in the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after acquiring an additional 18 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the topic of several analyst reports. Stephens cut their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Barclays lowered their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday. Wells Fargo & Company lifted their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Robert W. Baird lifted their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Finally, Cantor Fitzgerald upped their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 16th. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Price Performance

Shares of UNH opened at $569.98 on Wednesday. The company has a market capitalization of $526.33 billion, a price-to-earnings ratio of 37.13, a price-to-earnings-growth ratio of 1.67 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The business has a 50-day moving average of $584.46 and a 200-day moving average of $536.30.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the previous year, the firm posted $6.56 earnings per share. The business’s revenue was up 9.2% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.